Management of impending rupture of the aorta with dissection.
D000629:Aminopropionitrile / Q000627:therapeutic use; D000818:Animals; D001014:Aortic Aneurysm / Q000150:complications* / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000601:surgery; D001019:Aortic Rupture / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control* / Q000601:surgery; D001794:Blood Pressure; D004562:Electrocardiography; D005263:Femoral Artery; D005500:Follow-Up Studies; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011433:Propranolol / Q000627:therapeutic use; D011674:Pulse; D011859:Radiography; D012110:Reserpine / Q000627:therapeutic use; D014294:Trimethaphan / Q000627:therapeutic use; D014422:Turkeys
D000629:Aminopropionitrile; D014294:Trimethaphan; D012110:Reserpine; D011433:Propranolol; D006145:Guanethidine